Abstract

The absence of a validated, large-scale artificial intelligence tool in transfusion medicine reflects the structural, public-service design of blood systems rather than any technological limitation. For these reasons public blood services must lead AI development within the regulatory window created by the SoHO Regulation.

Downloads

Authors

Massimo La Raja Transfusion Medicine Department of Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy ORCID

Vincenzo De Angelis ESTM – European School of Transfusion Medicine ORCID

Giovanni Camisasca Transfusion Medicine and Blood Establishment, Holy Trinity Hospital Borgomanero, Borgomanero, Italy ORCID

Luis Larrea Transfusion Center of the Valencian Community, Valencia, Spain; Department of Medicine & Surgery, Health Sciences School, Universidad Cardenal Herrera-CEU, Valencia, Spain ORCID

  • Abstract viewed - 435 times
  • pdf downloaded - 0 times